Costs and Expenses in USD of Terns Pharmaceuticals, Inc. from Q1 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Terns Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2020 to Q3 2025.
  • Terns Pharmaceuticals, Inc. Costs and Expenses for the quarter ending September 30, 2025 was $27.7M, a 11.1% increase year-over-year.
  • Terns Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending September 30, 2025 was $108M, a 8.5% increase year-over-year.
  • Terns Pharmaceuticals, Inc. annual Costs and Expenses for 2024 was $102M, a 0.67% decline from 2023.
  • Terns Pharmaceuticals, Inc. annual Costs and Expenses for 2023 was $103M, a 65.3% increase from 2022.
  • Terns Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $62M, a 22% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)

Terns Pharmaceuticals, Inc. Quarterly Costs and Expenses (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $108M $27.7M +$2.78M +11.1% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $106M $27.4M +$1.85M +7.23% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-05
Q1 2025 $104M $27.4M +$1.98M +7.79% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $102M $25.9M +$1.89M +7.86% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-20
Q3 2024 $100M $24.9M -$8.25M -24.8% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 $108M $25.5M +$4.38M +20.7% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-05
Q1 2024 $104M $25.4M +$1.29M +5.34% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 $103M $24.1M +$7.23M +43% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-20
Q3 2023 $95.3M $33.2M +$15.9M +91.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $79.4M $21.2M +$7.08M +50.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $72.4M $24.2M +$10.3M +74.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $62M $16.8M +$1.95M +13.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $60.1M $17.3M +$5.42M +45.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $54.7M $14.1M +$3.27M +30.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $51.4M $13.8M +$529K +3.98% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $50.9M $14.9M +$6.11M +69.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 $44.8M $11.9M +$3.13M +35.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $41.6M $10.8M +$721K +7.14% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $40.9M $13.3M +$3.87M +41.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $37M $8.77M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-07
Q3 2020 $8.74M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $10.1M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $9.42M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14

Terns Pharmaceuticals, Inc. Annual Costs and Expenses (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $102M -$687K -0.67% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 $103M +$40.5M +65.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
2022 $62M +$11.2M +22% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $50.9M +$13.8M +37.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 $37M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.